triplet regimens in braf-mutant metastatic crc
Published 5 years ago • 199 plays • Length 7:02Download video MP4
Download video MP3
Similar videos
-
2:07
triplet regimen improves responses in braf v600e metastatic crc
-
4:19
targeting braf in metastatic crc
-
6:01
beacon trial: triplet therapy in braf v600e–mutated mcrc
-
1:00
dr. kopetz discusses triplet therapy for braf-mutant crc
-
1:51
dr. eng discusses the beacon crc study in braf-mutated crc
-
1:44
dr. kopetz discusses the treatment of braf-mutant crc
-
3:25
first-line triplet in braf mcrc
-
1:11
dr. kopetz on the rationale for the beacon crc study in braf v600e-mutant mcrc
-
1:32
dr. flaherty on the rationale to explore triplet therapy in braf v600e-mutant melanoma
-
0:54
triplet therapy for certain patients with metastatic crc shows promise, but more research is needed
-
1:09
dr. kopetz on updated data from beacon crc study in braf v600e–mutant crc
-
7:09
treatment of braf-mutated metastatic colorectal cancer
-
2:18
prognosticating braf-mutant mcrc
-
2:24
real-world management of patients with braf-v600e mcrc
-
0:54
dr. kopetz on safety data from beacon crc trial in braf v600e-mutant mcrc
-
3:42
evidence in braf-mutant crc tumors
-
2:16
dr. kim on treatment for braf-mutant colon cancer
-
2:33
braf mutations in colorectal cancer
-
0:58
targeting wnt in braf-mutant colorectal cancer